Stem cell research is poised to revolutionise many aspects of biomedical research [1, 2]. In
consequence, in this field of study, research output and the number of active researchers …

New solutions are needed to regenerate hearts damaged by myocardial infarction, to
overcome bad prognosis of patients with heart failure, and to address the shortage of heart …

Myocardial tissue engineering aims to repair, replace, and regenerate damaged cardiac
tissue using tissue constructs created ex vivo. This approach may one day provide a full …

Cardiovascular diseases (CVD) constitute a major fraction of the current major global
diseases and lead to about 30% of the deaths, ie, 17.9 million deaths per year. CVD include …

Cardiac disease is one of the most common causes of death in the world. Currently,
surgically invasive therapies, such as implantable devices and, ultimately, heart …

In the developed world, cardiovascular disease is responsible for the loss of more human
lives than all cancers combined. Due to the minimal intrinsic ability of the adult heart to …

Cardiovascular disease is the number one killer worldwide, with myocardial infarction (MI)
responsible for approximately 1 in 6 deaths. The lack of endogenous regenerative capacity …

In the developed world, cardiovascular disease is responsible for the loss of more human
lives than all cancer combined. Due to the minimal intrinsic ability of adult heart to …

Cell therapy is a new concept to repair diseased organs. For patients with myocardial
infarction, heart failure, and congenital heart diseases cell based therapies might represent …

Congestive heart failure, which often occurs progressively following a myocardial infarction,
is characterized by impaired myocardial perfusion, ventricular dilatation, and cardiac …